Research Triangle Park biotech companies accelerate drug development with Anilocus CRO services, leveraging the world’s largest research park ecosystem, home to seven top-10 global CROs and 790 life sciences companies with specialized preclinical research expertise.
Philadelphia’s biotech companies leverage Anilocus CRO services to accelerate drug discovery in “Cellicon Valley,” home to 10% of global cell and gene therapy companies, with specialized regulatory expertise for FDA proximity and comprehensive preclinical research support.
Anilocus provides comprehensive mutagenicity testing services including bacterial mutation assays, mammalian cell gene mutation studies, and in vivo mutagenicity testing to assess genetic mutation potential and support regulatory submissions for drug development programs.
Anilocus provides comprehensive genotoxicity testing services including Ames test, micronucleus assay, chromosomal aberration studies, and comet assay to assess DNA damage potential and mutagenic risk for regulatory compliance and drug safety evaluation.
Anilocus provides specialized preclinical contract research organization (CRO) services to Basel’s biotech and pharmaceutical companies, offering comprehensive drug discovery support including in vivo studies, pharmacokinetics, pharmacodynamics, and regulatory compliance expertise. We accelerate research timelines for companies developing breakthrough therapies in Switzerland’s premier pharmaceutical hub.
Anilocus provides specialized preclinical contract research organization (CRO) services to Munich’s biotech and pharmaceutical companies, offering comprehensive drug discovery support including in vivo studies, pharmacokinetics, pharmacodynamics, and regulatory compliance expertise. We accelerate research timelines for companies developing breakthrough therapies in Germany’s leading biotechnology hub.
Anilocus provides comprehensive general toxicology studies including acute, subacute, and chronic toxicity testing with MTD determination, NOAEL estimation, and dose-range finding to evaluate drug safety and establish appropriate dosing parameters for regulatory submissions.
Anilocus provides comprehensive preclinical toxicology testing services including general toxicity, clinical pathology, genotoxicity, reproductive toxicology, and safety pharmacology studies to support drug development programs from early discovery through regulatory submission with expert scientific guidance.
Anilocus provides specialized preclinical contract research organization (CRO) services to biotech and pharmaceutical companies in the UK Golden Triangle, offering comprehensive drug discovery support including in vivo studies, pharmacokinetics, pharmacodynamics, and regulatory compliance expertise. We accelerate research timelines for companies developing breakthrough therapies in Britain’s premier life sciences cluster.
Anilocus provides specialized preclinical contract research organization (CRO) services to Montreal’s growing biotech and pharmaceutical companies, offering comprehensive drug discovery support including in vivo studies, pharmacokinetics, pharmacodynamics, and regulatory compliance expertise. Located in Canada’s innovation hub, we accelerate research timelines for companies developing breakthrough therapies.
Bold ideas and breakthrough research. Expert analysis on the innovations and drug development for the most important people in the world: patients.
Use this form to send your questions to our research team about our preclinical contract research services.
We are here to help!
